Jubilant Biosys Opens New Noida Facility to Double Early Chemistry Scale-Up Capacity

Jubilant Biosys, a subsidiary of Jubilant Pharmova and a global contract research, development, and manufacturing organization (CRDMO), has announced the opening of a new facility in Noida, India. The company states that this expansion doubles its early chemistry scale-up capacity. Jubilant Biosys operates across five sites located in India and Europe, providing services in drug discovery and development.

The newly launched Noida facility is expected to enhance the company’s capabilities in early-stage chemistry processes. This addition aligns with Jubilant Biosys’ ongoing efforts to expand its infrastructure to support pharmaceutical research and development. The company emphasizes that the increased capacity will enable it to better serve clients by accelerating timelines for drug discovery projects.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 13, 2026

Author

GOAI